TP53 and breast carcinoma: Recent studies suggest that activation of AR by androgen directly stimulates the expression of tumor suppressor PTEN and KLLN, a newly identified tumor suppressor gene which shares a bidirectional promoter with PTEN, resulting in cell growth inhibition and transcriptionally activation of p53/p73-mediated apoptosis in breast cancer [22,23].